Iowa Medicaid Drug Utilization Review Commission
New Public Comment Policy
Any data that are to be referenced during the Public Comment period(s) should be limited to published, peer reviewed literature only. “Data on file” and “articles submitted for review” are not considered published, peer reviewed literature and should not be referenced during public testimony. All referenced data that is to be presented should be submitted to the DUR professional staff electronically to info@iadur.org AT LEAST ONE WEEK PRIOR TO THE MEETING DATE for consideration and distribution to the Commission members.
DUR Commission Members
- Mark Graber, M.D., FACEP, Chairperson
- Laurie Pestel, Pharm.D., Vice Chairperson
- Larry Ambroson, R.Ph.
- Casey Clor, M.D.
- Brett Faine, Pharm.D.
- Craig Logemann, R.Ph., Pharm.D., BCPS
- Susan Parker, Pharm.D.
- Richard Rinehart, M.D.
- Sara Schutte-Schenck, D.O., FAAP
Professional Staff
- Thomas Kline, D.O. — Medical Director, Iowa Medicaid Enterprise
- Pam Smith, R.Ph. - DUR Project Coordinator